This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Antinuclear Antibody Test Market

Market Insights on Antinuclear Antibody Test covering sales outlook, demand forecast & up-to-date key trends

Antinuclear Antibody Test Market by Product Type, Technique, Application, End User & Region - Forecast 2022-2032

Antinuclear Antibody Test Market Outlook

The antinuclear antibody test market is likely to record a strong CAGR of 8% during the forecast period. The antinuclear antibody test market is currently valued at US$ 7.4 Bn in 2022 and is likely to reach US$ 17.25 Bn by 2032.

Report Attribute

Details

Estimated Base Year Value (2022)

US$  7.4 Bn

Anticipated Forecast Value (2032)

US$  17.25 Bn

Projected Growth Rate (2022-2032)

8% CAGR

Sales of antinuclear antibody test kits have risen as major players are mostly working on developing advanced test kits and solutions.

Increased internal pathological testing departments in hospitals are also projected to contribute to the growth of the antinuclear antibody test market share.

The report sheds light on the factors improving the sales of antinuclear antibody tests and, in turn, the opportunities for market players. However, the antinuclear antibody test market also faces some challenges, which might limit the antinuclear antibody test market share from reaching its potential.

Some of the key antinuclear antibody test market trends promoting the demand for antinuclear antibody test include the services providers and manufacturers that are anticipated to utilize the advantage of the growth opportunities shaped by the rapid advancement in children's health care infrastructure and surge in the precautionary diagnosis of autoimmune disorders.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Dynamics of the Antinuclear Antibody Test Market Share

An increase in the demand for preventive diagnosis and constantly increasing the prevalence of systemic lupus erythematous diseases across the globe are significant factors that are projected to propel the global antinuclear antibody test market.

Furthermore, increasing the prevalence of rheumatoid arthritis, a recurrent upsurge of scleroderma is anticipated to considerably increase the demand for antinuclear antibody test kits and propel the growth of the sales of the antinuclear antibody test kits.

As per the data published by the center for disease control and prevention (CDC), it is expected that over 17000 new patients with systemic lupus erythematous are diagnosed in the US alone.

The increasing prevalence of lupus and autoimmune disorders is anticipated to drive the demand for the antinuclear antibody test, substantially fueling the market growth.

Additionally, the growing investment in start-ups offering preventative healthcare tests is expected to surge the service and delivery capacity of the antinuclear antibody test kit.

However, rising false positive test and parity results, combined with low awareness, are major factors restraining the growth of the antinuclear antibody test market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region holds the Highest Growth Potential in the Antinuclear Antibody Test Market

The global antinuclear antibody test market is segmented into the following regions - North America, Europe, Latin America, South Asia, East Asia, Oceania, and the Middle East & Africa.

North America holds a significant regional market for the antinuclear antibody test due to developed health care infrastructure, high test service adoption, and wide product availability in the region.

In East Asia, China is dominating the antinuclear antibody test market due to widespread screening for the antinuclear antibody test additionally the presence of large and local manufactures.

Latin America antinuclear antibody test market is anticipated to show a lower growth rate owing to the use of traditional blood screening techniques.

South Asia is anticipated to show a higher growth rate due to the growing adoption of advanced diagnostic technologies.

Growth in the Middle East and Africa is considerably low due to lower awareness about the antinuclear antibody test in the region.

How is the Competitive Landscape in the Antinuclear Antibody Test Market

The key players of the antinuclear antibody test market are focusing on enhancing and adopting strategies like enhancing the durability, sizes and its use to thrive business. This is driving down the sales of antinuclear antibody tests.

Some of the key participating players indulged in the sales of antinuclear antibody test are:

  • Zeus Scientific Inc.
  • Antibodies Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories
  • ERBA Diagnostics Inc.
  • EUROIMMUN AG
  • Trinity Biotech plc
  • Alere Inc.
  • Inova Diagnostics
  • Immuno Concepts

These market players are anticipated to drive the antinuclear antibody test market by introducing new products and expanding geographically.

The antinuclear antibody test market has witnessed a number of mergers and acquisitions between the top players in the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 8% from 2022 to 2032

Base year for estimation

2022

Historical data

2015 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Product type, Application, End Users, Region

Regional scope

North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa (MEA)

Country scope

U.S., Canada, Mexico, Brazil, Germany, Italy, France, U.K, Spain, Russia, China, Japan, South Korea, India, Malaysia, Thailand, Indonesia, Australia & New Zealand, GCC, S. Africa, N. Africa

Key companies profiled

Zeus Scientific, Inc., Antibodies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, ERBA Diagnostics Inc., EUROIMMUN AG, Trinity Biotech plc, Alere Inc., Inova Diagnostics, Immuno Concepts

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The antinuclear antibody test market grows at a rate of % CAGR during the forecast period 2022 to 2032.

Key players holding a substantial antinuclear antibody test market share include Zeus Scientific, Inc., Antibodies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, ERBA Diagnostics Inc., EUROIMMUN AG, Trinity Biotech plc, Alere Inc., Inova Diagnostics, Immuno Concepts.

Demand for antinuclear antibody test is likely to rise on the back of increased internal pathological testing departments in hospitals are also projected to contribute to the growth of the antinuclear antibody test market share.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Antibody Therapy Market

Published : March 2022

Healthcare

Bispecific Antibody Market

Published : July 2020

Healthcare

Antibody Isotyping Kits Market

Published : October 2019

Healthcare

Anti Neurofilament L Antibody Market

Published : August 2019

Google translate

Antinuclear Antibody Test Market